Skip to main content
Premium Trial:

Request an Annual Quote

Raynard Kington, Elias Zerhouni, Jonathan Sheridan, John Elling

Raynard Kington became the acting director of the National Institutes of Health, following the departure of Elias Zerhouni, as of Oct. 31. Kington has taken over the post until President-elect Barack Obama appoints a new director. He has served as Zerhouni’s deputy since 2003. Prior to that, he was associate director of NIH for behavioral and social sciences research.

Jonathan Sheridan is the new president and CEO at Integrated Genomics, a bioinformatics products and services provider that specializes in microbial genomics. He takes over from John Elling who will remain chairman of the board.
Prior to Integrated Genomics, Sheridan was VP of commercial operations at HTG, where he was responsible for forming new business partnerships with pharmaceutical and life sciences companies, establishing research agreements with academic institutions, and managing the global commercial sales and marketing teams.
Sheridan also held senior positions with PerkinElmer Life and Analytical Sciences, Epicentre Biotechnologies, Genomica, Lion Biosciences, PerkinElmer Cetus, Beckman Coulter, and Monsanto.

Filed under

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.